Molecular Biometrics, Inc.

When Shire PLC closes its $750 million acquisition of regenerative medicine firm Shire Regenerative Medicine Inc. (ABH) in the second or third quarter, it will mark a quiet but significant shi

Investments for start-ups seeking their first infusion of venture capital continue to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising ne

Auxogyn: Improving the Odds for IVF Start-up Auxogyn Inc. believes it has found a way to increase the success rate of in-vitro fertilization (IVF) procedures. Auxogyn's new, noninvasive technology

Increasing the odds in IVF 1490 O'Brien Drive Suite A Menlo Park, CA 94025 Phone: (650) 641-2429 Web Site: www.auxogyn.com Contact: Lissa Goldenstein, President & CEO Industry Segment: Reproductive Me